ClinicalTrials.gg
Enrolling by invitationNCT07727304Updated Oct 16, 2026

Implementation of Acute Heart Failure Checklist

An interventional study of CAEP Acute Heart Failure (AHF) Best Practices Checklist Implementation and Usual care in Acute Heart Failure (AHF) and Implementation Research, sponsored by Ottawa Hospital Research Institute. Enrolling by invitation at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-16.

Primary conditionnone(registry's first term: Emergencies)No conditionIs this wrong?Emergencies describes something many studies share rather than a condition a study is about. The study names no condition we can place it under, so it is not compared with other studies by condition.

Sponsored by Ottawa Hospital Research Institute · Not applicable, Interventional, and Treatment

Updated Oct 16, 2026Now Enrolling by invitationStart date movedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
5,040
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Patients with acute heart failure (AHF) commonly present to the emergency department (ED) with difficulty breathing and often have poor outcomes or death. Care of AHF is very complex and, unfortunately, there are no specific guidelines for how physicians should manage AHF in the ED. The investigators recently created the Canadian Association of Emergency Physicians (CAEP) AHF Best Practices Checklist, a concise document that provides specific guidance for ED care.

Our ultimate goal is to conduct a 12-site cluster study to introduce the CAEP AHF Checklist in multiple EDs. Before the investigators can do so, it is essential to demonstrate feasibility in a smaller-scale study. Our objective for this application is to conduct an internal pilot study to demonstrate feasibility of measuring implementation outcomes and refine the protocol if necessary. The investigators will develop strategies to encourage successful adoption of the Checklist by physicians in the ED and allocate 4 large Ontario EDs to implement the Checklist for 1,700 adult AHF patients.

This study will be very important for patients and the healthcare system. If the investigators show that the CAEP AHF Checklist improves patient management and outcomes, this would lead to widespread uptake of the Checklist by all EDs in Canada.

Read the detailed description

Background: Heart failure is a syndrome that results from impairment of ventricular filling or ejection of blood. Patients with acute heart failure (AHF) commonly present to the emergency department (ED) with increased shortness of breath and often have poor outcomes or death. Management of AHF is very complex and entails assessment, multiple treatment options, and the difficult decision of whether to hospitalize or discharge. Unfortunately, there are no specific guidelines for how to manage AHF in the ED. The Canadian Cardiovascular Society (CCS) has very detailed high-quality guidelines for heart failure, but these are not specific for AHF or the ED setting.

The investigators recently created the Canadian Association of Emergency Physicians (CAEP) AHF Best Practices Checklist by adapting the CCS guidelines with a panel of 32 emergency physicians, cardiologists, intern-ists, methodologists, and patients. This concise document provides specific guidance for ED physicians and was recently published (Can J Emerg Med Sept 2025).

Study Objective: Our overall goal is to improve care of AHF patients in Canadian EDs and our specific objective is to conduct an implementation study of the CAEP AHF Checklist to decrease mortality and morbidity.

Methods: Design: Cross-sectional 4-sequence 5 period stepped-wedge cluster study in which the "clinical intervention" is the CAEP AHF Checklist, and the "implementation intervention" is the introduction of the Checklist into ED physician practice. Over 30 months, 3 hospitals will cross over every 6 months from the control to the intervention period. There will be a 2-month transition period. Setting: 12 large EDs in 5 provinces. Subjects: All physicians managing AHF in the ED are the primary study participants (emergency, medicine, cardiology, and hospitalists). The patients to be included are consecutive adults age >18 who present with shortness of breath due to AHF. Interventions: The clinical intervention is the CAEP AHF Checklist and the implementation intervention are the behaviour change strategies to encourage the adoption of and adherence to the Checklist into the practice of the physicians managing AHF patients (during the intervention periods of the trial). Outcomes: The primary outcome will be a composite of 3 clinical effectiveness variables: 1) Mortality \<30 days, 2) Deterioration post index visit admission, requiring endotracheal intubation or non-invasive ventilation, or 3) Relapse back to ED requiring hospital admission \<14 days. Secondary effectiveness outcomes include any of the individual com-ponents of the composite primary outcome. Secondary implementation outcomes include adherence to the Checklist by review of quality indicators and surveys to measure penetration and acceptability. Data Analysis: The primary outcome will be analyzed according to the intention to treat principle, adhering to the randomized schedule of implementation. The unit of analysis will be the individual patient using mixed effects logistic regression accounting for the stepped wedge design. A priori subgroups will be sex male/female, age >75/\<75 years, and admitted/discharged. Sample Size: The investigators estimate a total enrollment of 5,040 cases.

Importance: If the investigators demonstrate that local implementation of the CAEP AHF Checklist improves patient management and outcomes, this justifies widespread scaling of the initiative to all EDs in Canada and elsewhere worldwide.

02

Conditions studied

  • Acute Heart Failure (AHF)
  • Implementation Research

Browse trials for

Keywords

  • Best Practices Checklist
  • Acute Heart Failure
  • Emergency Department
  • Guidelines
  • Implementation
03

In context

Lead sponsor

Ottawa Hospital Research Institute is the lead sponsor of 547 studies on the registry; 99 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All resident and staff physicians managing patients with AHF in the ED are the primary study participants and this includes emergency, medicine, cardiology, and hospitalists.
  • The patients that will be included are consecutive adults age >18 years and who present to the ED with recent onset of or recent increase in shortness of breath due to AHF, as determined by health records review.
  • Eligibility of patients will be reviewed by the blinded study Steering Committee.
  • Included will be both patients subsequently admitted to hospital and those discharged from the ED, as both will be impacted by the recommendations of the CAEP AHF Checklist.

Exclusion criteria

Exclusion Criteria:

  • who do not fit the definition of AHF;
  • if the primary reason for the ED visit was not AHF (e.g. pneumonia, pulmonary embolism);
  • who have acute myocardial infarction (either ST elevation or non-ST elevation) diagnosed in the ED, because the primary problem for these patients is not heart failure and they require specialized treatment beyond the scope of the Checklist; or
  • who are considered terminal, with death expected within 60 days.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
5,040 participants (estimated)

Study arms

  • Experimental
    CAEP AHF Checklist Implementation

    Implementation of the CAEP Acute Heart Failure (AHF) Best Practices Checklist in emergency departments. This includes both the clinical intervention (use of the Checklist to guide assessment, treatment, and disposition of AHF patients) and implementation strategies to promote uptake, such as physician education sessions, local champions, reminders, audit and feedback, and access to a smartphone application

    Behavioral: CAEP Acute Heart Failure (AHF) Best Practices Checklist Implementation

  • Other
    Usual Care

    Usual emergency department care for patients with acute heart failure prior to implementation of the CAEP AHF Checklist, with no exposure to active implementation strategies.

    Other: Usual care

Interventions

  • BehavioralCAEP Acute Heart Failure (AHF) Best Practices Checklist Implementation

    Implementation of the CAEP Acute Heart Failure (AHF) Best Practices Checklist to guide physician assessment, treatment, and disposition of patients presenting with AHF in the emergency department. The intervention includes structured implementation strategies to support behavior change and uptake, including identification of local physician champions, education sessions and presentations, review of barriers and facilitators, development of local action plans, reminders, audit and feedback on adherence, and access to a smartphone application providing the Checklist as a point-of-care reference.

  • OtherUsual care

    Standard emergency department care for patients with acute heart failure prior to implementation of the CAEP AHF Checklist, with no exposure to active implementation strategies.

06

What researchers measure

Primary outcomes

  1. All-cause mortality

    Time frame: within 30 days

  2. Number of Participants With Deterioration During the Index Visit

    deterioration during index visit, defined as requiring endotracheal intubation or mechanical non-invasive ventilation

    Time frame: within 24 hours

  3. Number of Participants With Relapse to the Emergency Department for a Related Medical Condition Requiring Hospital Admission Within 14 Days

    Relapse back to the emergency department for a related medical condition requiring hospital admission within 14 days of the index emergency department visit.

    Time frame: Within 14 days of the index emergency department visit

Secondary outcomes

  1. Length of Stay in the Emergency Department

    Emergency department length of stay for the index visit.

    Time frame: Up to 14 days following the index emergency department visit

  2. Number of Participants Admitted to Hospital Immediately or Within 30 Days

    Hospital admission occurring during the index emergency department visit or within 30 days of the index visit.

    Time frame: Within 30 days of the index emergency department visit

  3. Length of Stay in Hospital

    Hospital length of stay for participants admitted during the index visit or within 30 days of the index emergency department visit.

    Time frame: Within 30 days of the index emergency department visit

  4. Number of Participants With a Repeat Emergency Department Visit

    Repeat emergency department visit for any reason following the index emergency department visit.

    Time frame: Within 14 days of the index emergency department visit

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Requests to be submitted to the Principal Investigator and the study team will review on a case-by-case basis.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Aug 2026 (actual). Primary completion is estimated for Dec 2029, 40 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 3, 2026
First posted
Jul 27, 2026
StartActual
Aug 15, 2026
Primary completionEst.
Dec 31, 2029
CompletionEst.
Jun 1, 2030
Last update
Oct 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Enrolling by invitation
changed Oct 16, 2026
Start date
Aug 1, 2026→Aug 15, 2026 (actual)
Oct 16, 2026
Contact
No study contact listed any more: removed i•••@ohri.ca · •••5555
Oct 16, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Ottawa Hospital Research Institute · Ottawa, CanadaContact removed i•••@ohri.ca · •••5555
Oct 16, 2026
Show all 1 update
  1. Oct 16, 2026
    Not yet recruiting→Enrolling by invitation
    Start date Aug 1, 2026→Aug 15, 2026 (now actual)
    Contact No study contact listed any more: removed i•••@ohri.ca · •••5555
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Ottawa Hospital Research Institute · Ottawa, CanadaContact removed i•••@ohri.ca · •••5555
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07727304
Collaborators
The Ottawa Hospital Academic Medical Association
Responsible party
Sponsor
First posted
Jul 27, 2026
Start date
Aug 15, 2026
Primary completion
Dec 31, 2029 (estimated)
Completion
Jun 1, 2030 (estimated)
Last update
Oct 16, 2026

Study contacts

Ian Stiell, MD, MSc
principal investigator · Ottawa Hospital Research Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion